Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

Satisfying International Classification of Disease-10 (ICD) diagnostic criteria of schizophrenia;
Positive and Negative Syndrome Scale (PANSS) total score ≥ 60

Refractory schizophrenia or Patients treated with sufficient clozapine for a minimum period of 6-8 weeks without improvement;
Participation into another clinical trial within the last month;
Patients previously or currently treated with amisulpride;
Patients receiving clozapine within the past 1 month or treated with long-acting formulation of antipsychotic medication within the past 2 months;
Patients receiving electric convulsive therapy or physical therapy within the past 1 month;
Patients with coexisting severe systemic diseases;
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia